Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Medtech 360 | Market Analysis | Latin America (Supplemental) | 2019

The Latin America GI endoscopy market will grow moderately during the forecast period because of the improving access to healthcare across the region and the concerted efforts of health systems to implement extensive screening programs, especially for CRC. Having said that, the unstable economic conditions in the region, as well as the practice of reusing GI endoscopy devices among health care facilities, will act as limiting factors for the market.

This Medtech 360 Report provides high-level market metrics for the GI endoscopy device market in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period.

Related Medtech Insights Reports

Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Gynecological Devices – Market Insights – Latin America
The Latin American gynecological device market will experience modest growth over the forecast period, driven primarily by increasing awareness of gynecological health and available treatment…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Latin America
The Latin American GI endoscopy devices market is projected to grow moderately through 2034, driven by ongoing innovation in both diagnostic and interventional applications of GI endoscopy…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…